<p>A: WB was used to detect the expression of pJNK, RARα, RARβ, pERK and pp38 after SP600125 treatment. B: CHP126 cells were treated with 5.0 nM bortezomib, 10.0 nM ATRA and 5.0 nM bortezomib plus 10.0 nM ATRA in the presence of SP600125, as well as under control conditions. The morphology of cells was observed by microscopy at the same magnification. The microphotographs shown are representative of three different experiments. The images were analyzed with the Leica software to determine the relative lengths of the neurites (C). Data are shown as the means ± SE (n = 3). D. WB was used to detect the expression of tau and β tubulin III with or without SP600125 treatment. BTZ = bortezomib.</p
<p>(A) Dose-response curve of bortezomib sensitivity in representative cell lines. The vertical axis...
AIM: To evaluate the effects of c-Jun N-terminal kinase (JNK) inhibition and signal blocking on hypo...
<p>HEK293T cells were treated with different concentrations of bortezomib and the levels of autophag...
<p>SH-SY5Y (A) and CHP126 (C) cells were treated with 5.0 nM bortezomib, 10.0 nM ATRA and 5.0 nM bor...
<p>SH-SY5Y and CHP126 cells were seeded and treated with bortezomib (A) or ATRA (B) for 96 h, and Tr...
<p>SH-SY5Y (A) and CHP126 (B) cells were incubated with 5 nM bortezomib, 10 nM ATRA and bortezomib p...
<p>(A) Viability assay evaluated by trypan blue exclusion was performed in BC3 (left panel) and BCBL...
<p>(A), nutlin-3 treated NGP cells, 16 µM (right) and vehicle control (left). (B), ATRA treated NGP ...
<p>(A) BC3 and BCBL1 cells were treated with bortezomib (20 nM for 16 hrs) with or without pre-treat...
<p>A. Cells were incubated with 5.0 µM ATRA, 20.0 nM bortezomib, 5.0 nM bortezomib, 10.0 nM ATRA and...
Background: Bortezomib is a selective and reversible inhibitor of the 26S proteasome that shows pot...
Background: Bortezomib is a selective and reversible inhibitor of the 26S proteasome that shows pot...
PURPOSE: The proteasome inhibitor bortezomib inhibited cell growth and angiogenesis in neuroblast...
<p><b>A, D:</b> Experimental protocol. <b>B, E:</b> Representative confocal digital images of BrdU (...
PURPOSE: The proteasome inhibitor bortezomib inhibited cell growth and angiogenesis in neuroblast...
<p>(A) Dose-response curve of bortezomib sensitivity in representative cell lines. The vertical axis...
AIM: To evaluate the effects of c-Jun N-terminal kinase (JNK) inhibition and signal blocking on hypo...
<p>HEK293T cells were treated with different concentrations of bortezomib and the levels of autophag...
<p>SH-SY5Y (A) and CHP126 (C) cells were treated with 5.0 nM bortezomib, 10.0 nM ATRA and 5.0 nM bor...
<p>SH-SY5Y and CHP126 cells were seeded and treated with bortezomib (A) or ATRA (B) for 96 h, and Tr...
<p>SH-SY5Y (A) and CHP126 (B) cells were incubated with 5 nM bortezomib, 10 nM ATRA and bortezomib p...
<p>(A) Viability assay evaluated by trypan blue exclusion was performed in BC3 (left panel) and BCBL...
<p>(A), nutlin-3 treated NGP cells, 16 µM (right) and vehicle control (left). (B), ATRA treated NGP ...
<p>(A) BC3 and BCBL1 cells were treated with bortezomib (20 nM for 16 hrs) with or without pre-treat...
<p>A. Cells were incubated with 5.0 µM ATRA, 20.0 nM bortezomib, 5.0 nM bortezomib, 10.0 nM ATRA and...
Background: Bortezomib is a selective and reversible inhibitor of the 26S proteasome that shows pot...
Background: Bortezomib is a selective and reversible inhibitor of the 26S proteasome that shows pot...
PURPOSE: The proteasome inhibitor bortezomib inhibited cell growth and angiogenesis in neuroblast...
<p><b>A, D:</b> Experimental protocol. <b>B, E:</b> Representative confocal digital images of BrdU (...
PURPOSE: The proteasome inhibitor bortezomib inhibited cell growth and angiogenesis in neuroblast...
<p>(A) Dose-response curve of bortezomib sensitivity in representative cell lines. The vertical axis...
AIM: To evaluate the effects of c-Jun N-terminal kinase (JNK) inhibition and signal blocking on hypo...
<p>HEK293T cells were treated with different concentrations of bortezomib and the levels of autophag...